drugset / Trial / NCT01901393

Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery

NCT01901393

Phase 4 Completed 100 enrolled Cumberland Pharmaceuticals
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the efficacy of intravenous ibuprofen compared to ketorolac for the treatment of postoperative pain as measured by patient pain intensity (Visual Analog Scale, VAS)

Timeline

Start
2013-07
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 800 mg Intravenous
Comparator Ketorolac Other / unclassified 30 mg Intravenous

Indications

No indication recorded.